Assort Health
Unicorn · $1.2BFounded 2023 · 30 employees · 38 known investors
Find your way into Assort Health
Sign up to see every warm intro you have to Assort Health
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Assort Health team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Assort provides voice AI agents for healthcare that use deep patient interaction data to proactively guide patients through their care journey, orchestrating tasks from intake and scheduling to billing and care gap closure.
Also known as Assort · Assort Health, Inc.
Founders & leadership
Assort Health was founded in 2023 by Jeffery Liu and Jon Wang.



Investors · 38
How we know: Chemistry's portfolio page · press coverage · research · assorthealth.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Coho Deeptech's portfolio page · Not right? Tell us
How we know: Cold Start Ventures's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Collective Liquidity's portfolio page · Not right? Tell us
How we know: Felicis Ventures's portfolio page · press coverage · svpost.com · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: First Round Capital's portfolio page · a partner's Signal profile · press coverage · research · startupintros.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the VCSheet dataset · research · assorthealth.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Lightspeed Venture Partners's portfolio page · press coverage · research · startupintros.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Menlo Ventures's portfolio page · funding news · press coverage · svpost.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: research · startupintros.com · Not right? Tell us
How we know: research · startupintros.com · Not right? Tell us
How we know: research · startupintros.com · Not right? Tell us
How we know: research · startupintros.com · Not right? Tell us
How we know: research · startupintros.com · Not right? Tell us
How we know: a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · press coverage · research · startupintros.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: research · startupintros.com · Not right? Tell us
How we know: research · startupintros.com · Not right? Tell us
How we know: press coverage · svpost.com · Not right? Tell us
Also in the syndicate · 12
Funding
SEC filings, press & company announcements$360M disclosed across 3 of 9 rounds · 2024–2026
- $120MSeries CJul 2026 · 2 sources
Menlo Ventures (lead)
Source ↗ - $120MraisedJun 2026 · 2 sourcesSource ↗
- $120MSeries CJun 2026 · 3 sources
Menlo Ventures (lead), Chemistry, Felicis, First Round Capital, Joe Montana, Lightspeed Venture Partners, Pioneer Fund, Quiet Capital, Tau Ventures
Source ↗ - Undisclosed amountSeries BOct 2025Source ↗
- Undisclosed amountSeries BSep 2025
Lightspeed Venture Partners (lead), A*, Chemistry, Felicis, First Round Capital, Liquid2, Pioneer Fund, Quiet Capital
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Valuation · disclosed
Disclosed eventsSource: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Company profile
researched Aug 2026Assort Health develops a platform of AI agents that handle patient-facing administrative work for healthcare provider organizations, beginning with inbound phone calls and expanding across the patient journey. The platform covers appointment scheduling and management, triage and intelligent routing, after-hours coverage, patient intake, insurance and eligibility checks, medication refills, lab requests, referral and fax automation, document processing, task management, waitlist management, two-way texting, online scheduling, and payment resolution. Assort markets four interconnected products: Concierge (always-on inbound handling), Activate (proactive outbound outreach for reactivation, waitlists, care-gap closure, no-show recovery, and payments), Orchestrate (automated care journeys covering intake, referrals, digital forms, insurance document processing, and post-visit follow-up), and Empower (a staff co-pilot with summarization, warm handoff, benchmarking, and operational insights). The products share a common "Patient Journey Memory" layer that carries patient context — language preference, visit history, open tasks, sentiment — across channels and interactions [0][2][4].
The company positions its offering around specialty-specific depth rather than general-purpose call automation. Its website cites training on more than 200 million patient interactions, 62,000 care protocols, and 1.6 million decision pathways, and coverage of 23+ specialties including orthopedics, dermatology, ophthalmology, women's health, pediatrics, primary care, ENT and allergy, pain management, cardiology, urology, neurology, gastroenterology, podiatry, behavioral health, radiology, oncology, and emergency medicine. Target organization types listed include FQHCs, health systems, and multi-specialty groups. In June 2026 the company announced an expansion into health system operations, naming John Muir Health among partnering systems [0][2][4].
A third-party profile describes the company somewhat differently and with lower figures (approximately 84 EHR integrations, 55 million patient interactions, 1.2 million edge cases, and about 40 employees), and its funding-round details conflict with the company's own announcements; these discrepancies should be treated with caution [7].
Founding story
Assort Health was founded in 2023 (one third-party source specifies May 2023) by Jon Wang and Jeffery (Jeff) Liu, who are described as bringing AI, healthcare, and machine learning experience from Apple, Stanford, Commure, and Meta. The company frames its origin around the administrative burden in healthcare — patients waiting up to 35 minutes to schedule an appointment, roughly 20 million patients booked with the wrong doctor annually in the US, 88% of appointments booked by phone, and call-center staff turnover near 45% annually — and a conviction that the problem had to be attacked at the "front door" of the health system rather than in the middle [4][5][7].
Business model
Assort Health sells software to healthcare provider organizations — specialty practices, multi-specialty groups, FQHCs, and health systems — that deploys AI agents against their existing EHR/PMS systems. The sources describe an enterprise B2B software relationship with expert onboarding and deployments measured in weeks, but do not disclose pricing, contract structure, or per-unit economics [0][2][4][7].
Not disclosed in the available sources; the company reports revenue growth (8x since Q4 2024 as of April 2025, and 20x over the 15 months preceding June 2026) without stating pricing or revenue figures [4][5].
Traction
The company reports serving hundreds of practices and thousands of providers across 23+ specialties, with 200M+ patient interactions powering its models and a 4.3/5 patient satisfaction rating across 344,000 patient reviews (an earlier 2025 release cited 4.6/5). Revenue grew 8x from Q4 2024 to April 2025 and 20x over the 15 months preceding June 2026. Reported operational outcomes include 99% scheduling accuracy and a 90%+ resolution rate (2025), $3.3M annual revenue per 100 providers, 115% labor capacity gains, and customer-specific results such as an 89% reduction in hold times, hold times cut from 11 minutes to 1 minute in 30 days at Peninsula Orthopaedic Associates, and $2.3M and $1.3M in captured revenue at unnamed customers. Activate was reported deployed across 1,000+ providers at launch, with a 64% referral scheduling conversion rate at SENTA Partners; the Referrals agent is cited as converting 79% of referrals into scheduled appointments [0][2][4][5][6].
Latest developments
In June 2026 Assort announced a $120M Series C led by Menlo Ventures at a $1.2B valuation, taking total funding above $222M, alongside an expansion into health system operations with partners including John Muir Health. In July 2026 it hired a Chief Revenue Officer, VP of Customer Success, and SVP of People from Samsara, Luma Health, and Gusto, and launched the Frontier Awards program. In August 2026 it named Dr. Sunny Eappen — former President and CEO of University of Vermont Health Network and former CMO of Brigham and Women's Hospital — as its first Chief Medical Officer, and unveiled Referrals, an AI agent that processes, triages, and follows up on referrals [4][6].
▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies
Market position
Assort describes itself as the most widely-used AI agents platform for the patient journey and claims the largest AI-powered patient access deployment among provider groups. External signals in the sources include a $1.2 billion valuation at the June 2026 Series C, selection to CB Insights' 2026 AI 100 list of most innovative AI startups, and coverage by Fierce Healthcare, Modern Healthcare, and Pulse 2.0. A third-party profile names Actium Health and Avaamo as broader or less specialized alternatives [0][4][6][7].
Assort's stated differentiation rests on the scale and specificity of its patient interaction dataset (described as the largest specialty-specific dataset in healthcare AI), the Synapse model that auto-generates practice-specific workflows and test cases so deployments go live in weeks rather than months, Patient Journey Memory that preserves context across channels and time, and breadth of coverage across the full patient journey rather than a single point solution. Customer quotes in the Series C release emphasize the platform-versus-point-solution framing and memory across interactions [0][2][4].
Technology
The platform is built on what the company describes as a proprietary specialty-specific patient interaction dataset, cited at 200M+ interactions (190 million in the June 2026 release), 62,000+ care protocols, and 1.6 million+ decision pathways. Synapse, Assort's proprietary AI model, ingests a customer's EHR history, SOPs, decision trees, and call recordings and combines them with the shared dataset to generate practice-specific workflows, edge cases, tests, and simulations, with automated QA and a self-reinforcing model that tunes agent performance. Patient Journey Memory maintains continuous per-patient context across channels. Earlier materials describe a "proprietary agentic state machine" that breaks interactions into discrete steps handled by specialized agents, plus thousands of specialty-specific tests and continuous automated system testing. The company reports deep integration with 15+ EHR and PMS platforms, including athenahealth; a third-party profile instead claims 84+ EHR integrations (Epic, Cerner, athenahealth, DrChrono) and HIPAA, HITRUST CSF, and SOC 2 Type 2 compliance [0][2][4][5][7].
Go-to-market
Direct enterprise sales via demo requests, supported by published customer success stories, patient-feedback data, and press coverage. The company runs an industry summit (Ascend 2026) and launched a Frontier Awards program in July 2026 recognizing healthcare leaders in patient access. Land-and-expand is implied by the product structure — starting with inbound call handling (Concierge) and expanding to outbound outreach, orchestration, and staff tooling — and by an announced push from specialty provider groups into health systems and academic medical centers [0][2][4][6].
Healthcare provider organizations: specialty and multi-specialty practices, ambulatory groups, FQHCs, community-based health systems, and academic medical centers. Named customers and referenced organizations include Chesapeake Healthcare, OrthoIndy, Peninsula Orthopaedic Associates, Cleaver Medical Dermatology, Barrington Orthopedic, NCRVA, Boston Bone and Joint Institute, MDCS Dermatology, SENTA Partners, and John Muir Health [0][4][5][6].
Geography
Headquartered in San Francisco, California, United States; customers referenced are US-based provider organizations. No international operations are described in the sources [4][5][7].
History
Since launching in 2023, Assort built what it describes as the first voice AI agent to schedule a specialty appointment, then expanded into a broader platform. It raised early capital from Four Acres, Tau Ventures, and angels, then announced a $26M total-raised milestone in April 2025 in a round co-led by First Round Capital and Chemistry with Quiet Capital participating. A September 2025 update noted a further $102M raise to scale its agentic AI patient access platform. In May 2026 it launched Activate, its outbound agent, and was named to the CB Insights AI 100. In June 2026 it raised a $120M Series C led by Menlo Ventures at a $1.2B valuation, bringing total capital raised above $222M, and announced expansion into health system operations. In July 2026 it added senior executives from Samsara, Luma Health, and Gusto and launched the Frontier Awards; in August 2026 it named Dr. Sunny Eappen as its first Chief Medical Officer and launched its Referrals agent [4][5][6].
Risks & controversies
No controversies are described in the sources. Data-consistency risks are apparent: the third-party profile [7] reports total funding of $105.5M across four rounds with round dates, sizes, and lead investors that conflict with the company's own announcements, lists employee counts of both '10000+' and 'about 16'/'over 40' within the same page, and cites materially different technical figures (55M interactions, 84+ EHRs) than the company's site. Most performance metrics available are self-reported by the company or drawn from customer testimonials on its own site, and are not independently verified.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Founder mafia
2 people who came through Assort Health went on to found or lead other companies.
Related companies · 4
Companies working in the same space as Assort Health.
Timeline · 10
launches, deals, and filingsAI agent that extracts and structures information from each referral, applies organization-specific eligibility and specialty criteria, identifies missing information, and works referrals to completion; reported to convert 79% of referrals into scheduled appointments and identify a better-fit provider in 50% of cases.
Former President and CEO of University of Vermont Health Network and former Chief Medical Officer of Brigham and Women's Hospital joins to support health system deployments.
Chief Revenue Officer, Vice President of Customer Success, and Senior Vice President of People hired following the $120M Series C.
Awards program recognizing clinicians, executives, and operators working on patient access, launched following the Series C and the company's Ascend 2026 summit.
Assort extended its patient access platform from provider groups to health systems ranging from large community-based organizations to academic medical centers; John Muir Health named as a partnering system.
Brings total capital raised to more than $222M. Announced alongside expansion into health system operations.
$120M source ↗
Assort Health included in CB Insights' annual list of the 100 most innovative artificial intelligence startups.
Outbound AI agent that proactively reaches patients to fill care gaps, reschedule appointments around disruptions, and accelerate referrals; reported deployed across 1,000+ providers.
Company update noting an additional $102M raised following the April 2025 announcement.
Round co-led by First Round Capital and Chemistry with participation from existing investor Quiet Capital, joining prior backers Four Acres, Tau Ventures, and angels from Athena Health, Astrana Health, Flatiron Health, Infinitus, Mammoth Biosciences, Mercury, PathAI, and Presto.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
In the news
▸Research sources · 8
primary sources listed
- Assort Healthassorthealth.com · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Assort Health do?
- Assort Health builds AI voice and text agents that automate patient access workflows for specialty medical practices and health systems.
- Who founded Assort Health?
- Assort Health was founded by Jeffery Liu, Jon Wang in 2023.
- Who are Assort Health's investors?
- Assort Health's investors include Alumni Ventures, avra, Chemistry, Coho Deeptech, Cold Start Ventures, Collective Liquidity, Felicis Ventures, First Round Capital and 18 more.
- How much funding has Assort Health raised?
- Assort Health has disclosed $360M raised across 3 of its 9 known rounds.

















